|Articles|January 1, 2002
PDT may aid patients with minimally classic CNV
Study of verteporfin therapy leads to new VIM Trial to determine effectof fluence rate, light dose
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
2
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Study maps thermal dynamics of glaucoma laser treatments
5











































.png)


